NASDAQ:CLSD
Delisted

Clearside Biomedical Stock Signals

etoro logo Buy CLSD
*Your capital is at risk
$0.410
+0 (+0%)
At Close: Mar 13, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Clearside BioMedical, Inc

General

Signal Type Signal Value Data
Score 0.000 65 days ( 40.58 %
Last Price $0.410 0 %
Performance History
7 Days
$0.410 $0.410
0%
30 Days
$0.410 $0.410
0%
12 Mos
$0.86 $0.410
-52.38%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.410 - $0.410
Trend - 3 mos -10.99 % High Width: 209.04 %
Pred. range - 3 mos $0.267 - $0.82 Low -34.97 % - 100.99 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Dec 17, 2025 - 59 days
RSI Short Pivot Signal Buy Very Low Dec 23, 2025 - 55 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 51.18
Signal Type Signal Value Importance Data
Trend - 12 mos 5.99 % Very High Width: 446.64 %
Pred. range - 12 mos N/A - $4.78 High -100.00 % - 1,066.27 %
Short MA 12 mos Buy Very High Nov 13, 2025 - 82 days
Long MA 12 mos Sell Very High Nov 21, 2025 - 76 days
Short/Long MA 12 mos Sell Very High Dec 05, 2025 - 67 days
Pivot Long Buy Low Dec 17, 2025 - 59 days
RSI Long Pivot Signal Buy Low Jan 14, 2026 - 41 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT CLEARSIDE BIOMEDICAL, INC
Clearside BioMedical
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an i...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE